Tag: Didronel

Patented in 1966 and approved for medical use in 1977, etidronate was the first bisphosphonate to be used clinically for bone-related disorders. Despite its historical significance, etidronate was eventually discontinued from the market for most uses due to its inherent pharmacological limitations and the emergence of superior alternative medications.

Didronel (etidronate) is a bisphosphonate medication that has been discontinued in the United States, which was primarily used to treat and manage several bone-related conditions. A bisphosphonate is a class of drugs that alters bone formation and breakdown in the body.